# Case Report: Amplified psychoanalysis? Psychoanalysis, OCD and MDMA in a clinical case study

**Authors:** Filippo Dellanoce

PMC · DOI: 10.3389/fpsyg.2026.1617428 · Frontiers in Psychology · 2026-03-11

## TL;DR

This case study explores combining MDMA with psychoanalysis to treat OCD, showing potential for accessing unconscious material and overcoming therapy barriers.

## Contribution

Introduces 'amplified psychoanalysis' as a novel integration of MDMA-assisted therapy and traditional psychoanalysis for OCD.

## Key findings

- MDMA-assisted therapy enhanced access to previously avoided memories and emotions in the patient.
- The combination appeared to strengthen the therapeutic alliance and emotional processing in OCD treatment.
- Altered states of consciousness facilitated progress in psychoanalytic work that had stalled previously.

## Abstract

This article investigates the novel therapeutic approach of “amplified psychoanalysis” through a detailed examination of the Ygg case, which offers a descriptive single-case illustration of the integration of MDMA-assisted therapy with traditional psychoanalytic treatment for obsessive-compulsive disorder (OCD). The study explores how subjective experience induced by MDMA can interact with an ongoing analysis, potentially enhancing psychoanalytic processes by facilitating access to unconscious material and helping to move beyond therapeutic impasses. The work is presented as a psychoanalytic single-case clinical narrative, acknowledging the value of such cases for generating nuanced insights into psychological phenomena rather than for demonstrating efficacy. In this case, the integration of MDMA experiences within an established psychoanalytic framework appeared to create specific therapeutic opportunities: the altered states of consciousness were experienced by the patient as allowing more direct access to, and processing of, previously avoided memories and affects. This combination may be particularly promising for OCD, where traditional approaches often face limitations; however, its efficacy requires systematic investigation beyond this psychoanalytic single-case clinical narrative. The clinical process analysis highlights several putative processes of change, including enhanced emotional processing, a strengthened therapeutic alliance, and improved access to traumatic memories. The study aims to contribute to both psychedelic therapy and psychoanalytic practice by offering a novel therapeutic perspective on the treatment of OCD. It suggests that “amplified psychoanalysis” may represent a promising direction for future research with larger samples and formal outcome measures.

## Linked entities

- **Chemicals:** MDMA (PubChem CID 1615)
- **Diseases:** obsessive-compulsive disorder (MONDO:0008114), OCD (MONDO:0001158)

## Full-text entities

- **Diseases:** OCD (MESH:D009771)
- **Chemicals:** MDMA (MESH:D018817)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13013444/full.md

## References

95 references — full list in the complete paper: https://tomesphere.com/paper/PMC13013444/full.md

---
Source: https://tomesphere.com/paper/PMC13013444